oxybutynin has been researched along with Xerophthalmia in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Xerophthalmia: Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study included a large number of patients followed for a long period and demonstrated the good effectiveness of treatment with oxybutynin for hyperhidrosis in the main sites of sweating." | 7.96 | Long-term results of the treatment of primary hyperhidrosis with oxybutynin: follow-up of 1,658 cases. ( da Silva, MFA; de Campos, JRM; Faustino, CB; Kauffman, P; Puech-Leão, P; Teivelis, MP; Wolosker, N, 2020) |
| "This study included a large number of patients followed for a long period and demonstrated the good effectiveness of treatment with oxybutynin for hyperhidrosis in the main sites of sweating." | 3.96 | Long-term results of the treatment of primary hyperhidrosis with oxybutynin: follow-up of 1,658 cases. ( da Silva, MFA; de Campos, JRM; Faustino, CB; Kauffman, P; Puech-Leão, P; Teivelis, MP; Wolosker, N, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wolosker, N | 1 |
| Kauffman, P | 1 |
| de Campos, JRM | 1 |
| Faustino, CB | 1 |
| da Silva, MFA | 1 |
| Teivelis, MP | 1 |
| Puech-Leão, P | 1 |
1 other study available for oxybutynin and Xerophthalmia
| Article | Year |
|---|---|
Long-term results of the treatment of primary hyperhidrosis with oxybutynin: follow-up of 1,658 cases.
Topics: Administration, Oral; Adolescent; Adult; Axilla; Drug Administration Schedule; Face; Female; Follow- | 2020 |